From Medscape Ophthalmology

Coverage from the

European Society of Retina Specialists 17th EURETINA Congress

September 07 - 10, 2017; Barcelona, Spain

September 07 - 10, 2017 Barcelona, Spain

EURETINA Retina Specialists Seek to Stem Myopia Epidemic In an effort to slow the explosive increase in myopia and its subsequent progression, retina specialists are recommending early intervention.
Medscape Medical News, September 8, 2017

Conference News

EURETINA Life- and Eye-Saving New Treatments for Uveal Melanoma
Medscape Medical News, September 14, 2017
EURETINA OCT Screening Cost-effective for Diabetic Retinopathy
Medscape Medical News, September 11, 2017
EURETINA Ranibizumab Beats Laser for Diabetic Retinopathy
Medscape Medical News, September 10, 2017

EURETINA Analysis Favors Aflibercept for Diabetic Macular Edema
Medscape Medical News, September 9, 2017
EURETINA Retina Specialists Seek to Stem Myopia Epidemic
Medscape Medical News, September 8, 2017
EURETINA European Retina Meeting Will Focus on Myopia Epidemic
Medscape Medical News, August 30, 2017

Popular News From EURETINA 2016

Predicting Anti-VEGF Response in Diabetic Macular Edema Response after 12 weeks of ranibizumab therapy can predict long-term outcomes in diabetic macular edema, a post hoc analysis suggests.
Medscape Medical News, Sep 13, 2016
Prognostic Tests at 1 Month Foretell Macular Edema Outcome In macular edema secondary to branch retinal vein occlusion, assessment a month after the first anti-VEGF treatment predicts long-term outcome better than baseline testing, a case series shows.
Medscape Medical News, Sep 12, 2016
No Laser on First-line Anti-VEGF for Diabetic Macular Edema One of the predictors of visual improvement in patients with diabetic macular edema is ranibizumab monotherapy, an analysis of the RESTORE data shows, but not everyone agrees with the findings.
Medscape Medical News, Sep 10, 2016

Medscape Ophthalmology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resource

AMD and Retinal Disease News & Perspectives

All material on this website is protected by copyright, Copyright © 1994-2018 by WebMD LLC. This website also contains material copyrighted by 3rd parties.